|
Name |
cis-Vaccenic acid
|
Molecular Formula | C18H34O2 | |
IUPAC Name* |
(Z)-octadec-11-enoic acid
|
|
SMILES |
CCCCCC/C=C\CCCCCCCCCC(=O)O
|
|
InChI |
InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/b8-7-
|
|
InChIKey |
UWHZIFQPPBDJPM-FPLPWBNLSA-N
|
|
Synonyms |
cis-vaccenic acid; 506-17-2; cis-11-Octadecenoic acid; (Z)-octadec-11-enoic acid; Asclepic acid; 11Z-Octadecenoic acid; VACCENIC ACID; (Z)-11-Octadecenoic acid; 11-Octadecenoic acid, (Z)-; cis-octadec-11-enoic acid; CHEBI:50464; 400K7322UW; C18:1n-7; VCA; trans-11-Octadecensaeure; Vaccenic acid, cis-; UNII-400K7322UW; MFCD00063187; cis-11-Vaccenic acid; 11-cis-Octadecenoic acid; 11(Z)-Octadecenoic acid; cis-D11-Octadecenoic acid; (Z)-octadec-11-enoicacid; SCHEMBL97463; (11Z)-octadec-11-enoic acid; CHEMBL1236642; DTXSID70881242; 11-Octadecenoic acid, (11Z)-; 11-OCTADECENOIC ACID, CIS-; LMFA01030076; ZINC14881303; AKOS022172997; DB04801; HY-113427A; CIS-.DELTA.11-OCTADECENOIC ACID; 18:1Z(N-7); CS-0136110; C21944; A871500; Q27095533; 4IF
|
|
CAS | 506-17-2 | |
PubChem CID | 5282761 | |
ChEMBL ID | CHEMBL1236642 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 282.5 | ALogp: | 6.5 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.289 |
Caco-2 Permeability: | -5.043 | MDCK Permeability: | 0.00003570 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.98 |
30% Bioavailability (F30%): | 0.996 |
Blood-Brain-Barrier Penetration (BBB): | 0.021 | Plasma Protein Binding (PPB): | 99.08% |
Volume Distribution (VD): | 0.718 | Fu: | 0.56% |
CYP1A2-inhibitor: | 0.269 | CYP1A2-substrate: | 0.206 |
CYP2C19-inhibitor: | 0.204 | CYP2C19-substrate: | 0.096 |
CYP2C9-inhibitor: | 0.202 | CYP2C9-substrate: | 0.991 |
CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.209 |
CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.022 |
Clearance (CL): | 2.63 | Half-life (T1/2): | 0.811 |
hERG Blockers: | 0.06 | Human Hepatotoxicity (H-HT): | 0.05 |
Drug-inuced Liver Injury (DILI): | 0.017 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.037 | Maximum Recommended Daily Dose: | 0.026 |
Skin Sensitization: | 0.939 | Carcinogencity: | 0.095 |
Eye Corrosion: | 0.933 | Eye Irritation: | 0.967 |
Respiratory Toxicity: | 0.849 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001555 | 1.000 | D0O1PH | 0.864 | ||||
ENC001775 | 0.932 | D0O1TC | 0.644 | ||||
ENC001593 | 0.905 | D0UE9X | 0.562 | ||||
ENC001099 | 0.895 | D07ILQ | 0.539 | ||||
ENC001699 | 0.839 | D0Z5BC | 0.500 | ||||
ENC001602 | 0.839 | D0OR6A | 0.468 | ||||
ENC001553 | 0.826 | D0Z5SM | 0.461 | ||||
ENC001688 | 0.800 | D09SRR | 0.451 | ||||
ENC001670 | 0.765 | D0XN8C | 0.450 | ||||
ENC001554 | 0.759 | D05ATI | 0.444 |